These findings suggest that PABPC1 up-regulation in prostate cancer cells can enhance androgen signaling and subsequently promote prostate cancer cell proliferation in both androgen-sensitive and castration-resistant stages of the disease. The gene discussed is PABPC1; the disease is prostate carcinoma.